Hepatocyte transplantation as a treatment for glycogen storage disease type 1a.
about
Hepatocyte transplantation program: Lessons learned and future strategiesDiminution of toxic copper accumulation in toxic milk mice modeling Wilson disease by embryonic hepatocyte intrasplenic transplantation.Production and characterization of murine models of classic and intermediate maple syrup urine diseaseTransplantation of fetal liver epithelial progenitor cells ameliorates experimental liver fibrosis in miceTreating inborn errors of liver metabolism with stem cells: current clinical developmentBarriers to the successful treatment of liver disease by hepatocyte transplantation.Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cellsDecellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantationNew potential cell source for hepatocyte transplantation: discarded livers from metabolic disease liver transplants.Bottom-up signaling from HGF-containing surfaces promotes hepatic differentiation of mesenchymal stem cells.Hepatic differentiation of amniotic epithelial cells.Efficacy of mesenchymal stem cells in suppression of hepatocarcinorigenesis in rats: possible role of Wnt signaling.Successful auto-implantation of hepatic cells in lung tissue: An animal study.Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease.The history and use of human hepatocytes for the treatment of liver diseases: the first 100 patients.Review article: a medicine based on cell transplantation -- is there a future for treating liver diseases?Autologous bone marrow stem cells in the treatment of chronic liver diseaseEmbryonic hepatocyte transplantation for hepatic cirrhosis: efficacy and mechanism of action.Liver transplantation for Wilson disease.A new technique for primary hepatocyte expansion in vitroRegenerative medicine as applied to general surgeryLiver gene therapy: advances and hurdles.Secondary causes of nonalcoholic fatty liver disease.Mesenchymal stem cell-derived hepatocytes for functional liver replacement.The use of cellular technologies in treatment of liver pathologies.How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology?Cellular aspects of liver regeneration.Corneal epithelial stem cell delivery using cell sheet engineering: not lost in transplantation.Management of Liver Failure: From Transplantation to Cell-Based Therapy.Glycogen storage disease types I and II: treatment updates.Stem cells in liver regeneration and therapy.Progress toward cell-directed therapy for phenylketonuria.Clinical applications of hepatocyte transplantation.Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives.Bioartificial liver systems: why, what, whither?Low therapeutic threshold for hepatocyte replacement in murine phenylketonuria.Regenerative medicine as applied to solid organ transplantation: current status and future challenges.Menstrual blood-derived mesenchymal stem cells differentiate into functional hepatocyte-like cells.Direct transdifferentiation of spermatogonial stem cells to morphological, phenotypic and functional hepatocyte-like cells via the ERK1/2 and Smad2/3 signaling pathways and the inactivation of cyclin A, cyclin B and cyclin ERestoring Ureagenesis in Hepatocytes by CRISPR/Cas9-mediated Genomic Addition to Arginase-deficient Induced Pluripotent Stem Cells.
P2860
Q26774608-D5CF24A4-FC73-4CBC-90BE-2CBE22004476Q33217543-60A9B157-9704-47A9-BE1F-873998E2C70AQ33238292-F4763CC2-4733-4B32-8048-4A4626F24B42Q33866469-2C119467-BCD1-4261-BA03-256A09B4AD62Q33870631-16B9B1BF-E41B-40BD-AC0A-C9223FBFE7E5Q34091618-E5A1002F-9F7B-4478-9305-C6AA85F82F53Q34157222-9CFB6A07-5C27-42F5-B564-11397F707125Q34488546-A971D48F-432E-447F-B61E-EECC57C4A9D0Q34673712-4C7D08BB-8E93-4C90-8E1E-9389FFF53482Q34786036-5BBE0F98-4F27-4CAF-A1ED-94300DA4D04FQ35012484-1C07D922-6AE2-4202-A293-5A05E1D73294Q35041516-B5831CBC-F3F0-425F-A8EC-69D8AC2F12B6Q35079330-53FCFAE0-7CEC-4B5A-8964-2306E222A27DQ35087066-EE2EE76F-37C5-443F-96D5-853494F6E52DQ35129278-D7B47025-13A7-4C8D-B965-0796876C1F67Q35209650-F03041F4-4907-477F-BFC8-53DBC52467E1Q35550572-088BAF7A-77FD-417E-B3D4-5EDF47718566Q35681501-9F2D6E97-A2B9-4EE5-8C7D-D7F4B5F86026Q35736533-EC720882-4C76-4FB7-BA01-CA8BB2FD644BQ35805123-49B2FD18-E3E5-4FC0-9FE0-4D879A10AF0AQ35892487-FA1DA713-D18F-4324-8C5D-82703054CADCQ35904443-0ABF16B8-AC2C-4467-86D6-F9533637515CQ35929072-0CCE65B6-6B71-42BD-A0B1-38D19386634DQ36052620-A3FFDFD7-3F9A-4A1B-8D62-DEF0C7BB6A2DQ36379723-6813EDAD-1A3F-400A-8E8F-A3491DF7C964Q36492605-2359FCBF-1E38-4075-9F1D-5556A4E9080DQ36609493-06A048F2-926E-4A4D-A0A9-5D18B405376EQ36633654-4D3ECC6F-F910-4D79-918C-8903F0D9AA80Q36680588-A205CBBA-50D1-48EC-B7E1-3F27C1933F03Q36739605-FEB44D11-BEA6-40E1-8B81-5DAB6A8931BCQ36954413-57A30F64-545A-4940-8F00-36CF4FE976AFQ37170974-E3136A7E-31B7-4433-8F2A-BD648E20D1EAQ37182937-B990DB20-4FB0-4CF5-8B8F-6AFC8C186A96Q37195905-70466C29-9A66-4CD7-A0AC-F8AC57A4EDD5Q37202810-0137B279-C69F-4FED-9D04-EE29D635AD1AQ37221675-89A2A7AC-4098-438B-B373-AD95BCEE0738Q37278992-8E4F114C-7976-42F6-BD58-382E927773B7Q37312922-E5B66B0A-F481-48C7-AA9D-A35E84E9CB2AQ37360201-6FB001CA-079B-4795-B64A-3AB1EF131BE2Q37501605-0CFB8A58-78AD-407E-B232-78B42F68254E
P2860
Hepatocyte transplantation as a treatment for glycogen storage disease type 1a.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Hepatocyte transplantation as a treatment for glycogen storage disease type 1a.
@en
Hepatocyte transplantation as a treatment for glycogen storage disease type 1a.
@nl
type
label
Hepatocyte transplantation as a treatment for glycogen storage disease type 1a.
@en
Hepatocyte transplantation as a treatment for glycogen storage disease type 1a.
@nl
prefLabel
Hepatocyte transplantation as a treatment for glycogen storage disease type 1a.
@en
Hepatocyte transplantation as a treatment for glycogen storage disease type 1a.
@nl
P2093
P1433
P1476
Hepatocyte transplantation as a treatment for glycogen storage disease type 1a.
@en
P2093
Alberto B Burlina
Anna Granato
Daniele Neri
Gianpiero Giron
Giorgio Gerunda
Maria-Teresa Vilei
Maurizio Muraca
Muzio Meroni
Paolo Feltracco
P304
P356
10.1016/S0140-6736(02)07529-3
P407
P577
2002-01-01T00:00:00Z